Ionis Pharmaceuticals, Inc.
IONS
Jodie situation report
Ionis Pharmaceuticals, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 10 directly disclosed connections are confirming.
- Cash balance decreased due to repayment upon maturity of the company's 0% Notes due 2026 in April 2026.
Invalidation: The isolated read changes if IONS's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind IONS
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
AZNAstraZeneca PLCpartnerApr 29, 2026 ▾
“WAINUA (Eplontersen) Collaboration with AstraZeneca Our financial results for the three months ended March 31, 2026 and 2025 reflected the cost-sharing provisions related to our collaboration with AstraZeneca to develop and commercialize WAINUA for the treatm…”
BIIBBiogen Inc.partnerApr 29, 2026 ▾
“Biogen Marketed Medicines SPINRAZA In 2012, we entered into a collaboration agreement with Biogen to develop and commercialize SPINRAZA.”
Depended on by
SRPTSarepta Therapeutics, Inc.competitorMar 2, 2026 ▾
“In addition, while Wave announced its intention to discontinue development of suvodirsen and suspend development of WVE-N531, it is conducting clinical trials for its exon 53 oligonucleotide, WVE-N531.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 9 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
IONS is currently a Leader in the organic co-movement group RNA-Targeted Biotech. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for IONS; it is not active in the latest market snapshot.